Cancer and male sexual dysfunction

Area of Science:

• Oncology
• Urology
• Men's Health

Background:

• Cancer treatments frequently lead to erectile dysfunction (ED) in male patients.
• ED in this population is often multifactorial, involving both physiological and psychological causes.
• Understanding the pathophysiology of ED is crucial for effective management.

Purpose of the Study:

• To provide a comprehensive overview of erectile dysfunction in men undergoing cancer treatment.
• To discuss the pathophysiology, evaluation, and treatment options for ED in cancer patients.
• To highlight the importance of understanding erection mechanisms for successful therapeutic interventions.

Main Methods:

• Review of current literature on erectile dysfunction in cancer patients.
• Analysis of the physiological and psychological mechanisms underlying ED.
• Compilation of available treatment modalities, including mechanical, surgical, and pharmacologic options.
• Discussion of recent advancements in understanding erection at organ, cellular, and molecular levels.

Main Results:

• Erectile dysfunction is a common complication of cancer therapy with diverse etiologies.
• A range of treatment strategies, from mechanical aids to systemic drugs, are available.
• Advances in understanding erection physiology have enabled novel therapeutic approaches.
• Successful ED treatment hinges on provider expertise in erection mechanisms and therapies.

Conclusions:

• Effective management of erectile dysfunction in cancer patients requires a thorough understanding of its causes and available treatments.
• New insights into erection mechanisms have led to improved therapeutic options.
• This article serves as a guide to the pathophysiology, evaluation, and treatment of ED in this patient group.